Related Experiment Video
Updated: Oct 12, 2025

Investigating the Spreading and Toxicity of Prion-like Proteins Using the Metazoan Model Organism C. elegans
Published on: January 8, 2015
FTLD-TDP assemblies seed neoaggregates with subtype-specific features via a prion-like cascade
Pierre De Rossi1, Amanda J Lewis2, Johanna Furrer1
1Department of Quantitative Biomedicine, University of Zurich, Zurich, Switzerland.
Pathological TDP-43 aggregates in FTLD-TDP subtypes show distinct prion-like seeding properties. FTLD-TDP-A seeds amplify faster than FTLD-TDP-C seeds, correlating with disease progression and informing subtype-specific therapies.
Area of Science:
- Neuroscience
- Molecular Biology
- Pathology
Background:
- Distinct TDP-43 aggregate morphologies characterize FTLD-TDP subtypes, but their formation and role in clinical differences are unclear.
- Evidence suggests pathological TDP-43 aggregates spread via a prion-like mechanism, yet molecular drivers remain unidentified.
Purpose of the Study:
- To compare the seeding properties of pathological aggregates from FTLD-TDP subtypes A and C.
- To investigate the mechanism of TDP-43 aggregate formation and its correlation with clinical heterogeneity.
Main Methods:
- Advanced microscopy techniques were employed to analyze patient-derived FTLD-TDP-A and FTLD-TDP-C aggregates.
- Cellular seeding models were used to assess the amplification and neoaggregation properties of these patient-derived seeds.
Main Results:
- FTLD-TDP-A seeds amplified more efficiently in a template-dependent manner than FTLD-TDP-C seeds, correlating with disease progression rates.
- Neoaggregates exhibited sequential phosphorylation with N-to-C directionality and subtype-specific timelines.
- FTLD-TDP-A neoaggregates formed large, densely packed fibrils, while FTLD-TDP-C neoaggregates were smaller and amorphous, reflecting in vivo pathology.
Conclusions:
- Cellular seeding models successfully replicate pathological diversity observed in FTLD-TDP subtypes.
- These models provide a valuable tool for developing subtype-specific therapeutics for FTLD-TDP.
Related Concept Videos
Amyloid Fibrils
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order...
Tail-anchoring of Proteins in the ER Membrane
Protein Complex Assembly
Many viruses self-assemble into a fully functional unit using the infected host cell to...
Translesion DNA Polymerases
TLS polymerases are found in all three domains of life - archaea, bacteria, and eukaryotes. Of the different classes of TLS polymerases, members of the Y family are fitted with specialized structures that...
Rab Cascades

